RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | ScienceDex

The notices it replaced

15 notices, oldest first, each with its awards since FY2014.

Year not statedRFA-CA-05-003None since FY2014
Year not statedRFA-CA-06-003None since FY2014
Year not statedRFA-CA-07-002None since FY2014
Year not statedRFA-CA-07-018None since FY2014
Year not statedRFA-CA-07-036None since FY2014
Year not statedRFA-CA-08-008None since FY2014
Posted 2008RFA-CA-09-007None since FY2014
Posted 2009RFA-CA-10-004None since FY2014
Posted 2011RFA-CA-12-003None since FY2014
Posted 2012RFA-CA-13-0026 awards
Posted 2013RFA-CA-14-00412 awards
Posted 2015RFA-CA-15-00315 awards
Posted 2015RFA-CA-16-00212 awards
Posted 2016RFA-CA-17-01110 awards
Posted 2017RFA-CA-18-00311 awards
Posted 2019RFA-CA-19-020This notice, closed · 11 awards

Replaced by RFA-CA-20-018.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards: 77; 77 new
Median first-year cost: $391,113; $34,697,185 in all
Institutions: 55; 73 contact PIs
Patents: 32; from 19 funded projects

Awards by fiscal year

14151617181920212223242526

Fiscal years 2014 to 2026.

Most frequent institutions

YALE UNIVERSITY5
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS3
CORNELL UNIVERSITY3
UNIVERSITY OF MINNESOTA3
UNIVERSITY OF WASHINGTON3

and 50 other institutions

Most frequent study sections

Special Emphasis Panel (ZCA1 TCRB-D (O1))11
Special Emphasis Panel (ZCA1 TCRB-Q (O2))10
Special Emphasis Panel (ZCA1 TCRB-9 (M1))7
Special Emphasis Panel (ZCA1 TCRB-J (M1))7
Special Emphasis Panel (ZCA1 TCRB-Q (J1))5

and 12 other study sections

77 awards under RFA-CA-19-020 and the notices it replaced
FY	Project	PIs	Institution	First-year cost	Study section
FY2020	T-cell Biofactories for targeting extracellular matrix1R33CA247739-01	Bhatnagar, Parijat	SRI INTERNATIONAL, CA	First-year cost $1,606,207	Study section ZCA1
FY2020	Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer1R33CA236681-01A1	Verhaak, Roel Gw Wei, Chia-Lin	JACKSON LABORATORY, ME	First-year cost $1,377,810	Study section ZCA1
FY2020	Comprehensive breakpoint analyses for simultaneous quantification of all DNA double strand break repair pathways1R33CA236670-01A1	Higginson, Daniel	SLOAN-KETTERING INST CAN RESEARCH, NY	First-year cost $1,322,190	Study section ZCA1
FY2020	Multiplexed imaging of chromatin folding and RNA profiles in cancer1R33CA251037-01	Muzumdar, Mandar Deepak Wang, Siyuan	YALE UNIVERSITY, CT	First-year cost $1,237,899	Study section ZCA1
FY2020	Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores1R33CA246448-01A1	Hall, Adam Roger	WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC	First-year cost $1,089,730	Study section ZCA1
FY2020	High-Throughput Screening Platform for Cancer Drug Discovery1R33CA240191-01A1	Recht, Michael	PALO ALTO RESEARCH CENTER, CA	First-year cost $720,575	Study section ZCA1
FY2020	Clinical implementations of spatial transcriptomics in tumors1R33CA246455-01	Ashenberg, Orr Chen, Fei Rodig, Scott J	BROAD INSTITUTE, INC., MA	First-year cost $449,518	Study section ZCA1
FY2020	High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer1R33CA246711-01	Fan, Rong Lu, Jun	YALE UNIVERSITY, CT	First-year cost $417,077	Study section ZCA1
FY2020	Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies1R33CA240181-01A1	Chaichana, Kaisorn Lee Cooks, Robert Graham Quinones-Hinojosa, Alfredo	PURDUE UNIVERSITY, IN	First-year cost $392,146	Study section ZCA1
FY2020	A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics1R33CA235294-01A1	Wang, Shaopeng	ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ	First-year cost $391,113	Study section ZCA1
FY2020	Time-resolved FRET-based allostery sensors for any protein kinase drug target1R33CA246363-01	Levinson, Nicholas Mark	UNIVERSITY OF MINNESOTA, MN	First-year cost $375,535	Study section ZCA1
FY2019	A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery1R33CA225549-01A1 · under RFA-CA-18-003	Luker, Gary DTavana, Hossein	UNIVERSITY OF AKRON, OH	First-year cost $476,844	Study section ZCA1
FY2019	A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells1R33CA229042-01A1 · under RFA-CA-18-003	Schneck, Jonathan P	JOHNS HOPKINS UNIVERSITY, MD	First-year cost $416,450	Study section ZCA1
FY2019	GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models1R33CA236687-01 · under RFA-CA-18-003	Breunig, Joshua John	CEDARS-SINAI MEDICAL CENTER, CA	First-year cost $413,100	Study section ZCA1
FY2019	Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation1R33CA229068-01A1 · under RFA-CA-18-003	Schiavinato Eberlin, Livia	UNIVERSITY OF TEXAS AT AUSTIN, TX	First-year cost $411,941	Study section ZCA1
FY2019	Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment1R33CA235319-01A1 · under RFA-CA-18-003	Yang, Jenny J.	GEORGIA STATE UNIVERSITY, GA	First-year cost $407,268	Study section ZCA1
FY2019	Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers1R33CA225498-01A1 · under RFA-CA-18-003	Chen, Sidi	YALE UNIVERSITY, CT	First-year cost $407,025	Study section ZCA1
FY2019	Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics1R33CA225458-01A1 · under RFA-CA-18-003	Gerber, Scott A.Kettenbach, Arminja Nadine	DARTMOUTH COLLEGE, NH	First-year cost $400,114	Study section ZCA1
FY2019	Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer research1R33CA240201-01 · under RFA-CA-18-003	Van Dam, Robert Michael	UNIVERSITY OF CALIFORNIA LOS ANGELES, CA	First-year cost $379,082	Study section ZCA1
FY2019	Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer1R33CA235302-01A1 · under RFA-CA-18-003	Brito, Ilana Lauren De Vlaminck, Iwijn Zipfel, Warren R	CORNELL UNIVERSITY, NY	First-year cost $349,262	Study section ZCA1
FY2019	Multiscale microscope for 3D cancer imaging in model organisms and organoids1R33CA235254-01 · under RFA-CA-18-003	Fiolka, Reto Paul	UT SOUTHWESTERN MEDICAL CENTER, TX	First-year cost $328,541	Study section ZCA1
FY2019	Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia1R33CA235597-01A1 · under RFA-CA-18-003	August, KeithSoper, Steven Allan	UNIVERSITY OF KANSAS LAWRENCE, KS	First-year cost $241,587	Study section ZCA1
FY2018	Pro-Codes: A novel vector and cell barcoding technology1R33CA223947-01A1 · under RFA-CA-17-011	Brown, Brian D	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY	First-year cost $421,587	Study section ZCA1
FY2018	Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform1R33CA223908-01 · under RFA-CA-17-011	Evens, Andrew M Huang, Tony Jun Konry, Tania Tali	NORTHEASTERN UNIVERSITY, MA	First-year cost $421,501	Study section ZCA1
FY2018	Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors1R33CA223904-01 · under RFA-CA-17-011	Cima, Michael J	MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA	First-year cost $416,667	Study section ZCA1
FY2018	An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer1R33CA225539-01 · under RFA-CA-17-011	Jiang, Ning Jenny	UNIVERSITY OF TEXAS AT AUSTIN, TX	First-year cost $396,959	Study section ZCA1
FY2018	CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer1R33CA225863-01 · under RFA-CA-17-011	Lu, Jun	YALE UNIVERSITY, CT	First-year cost $395,674	Study section ZCA1
FY2018	Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level1R33CA223581-01A1 · under RFA-CA-17-011	Cheng, Ji-Xin	BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA	First-year cost $390,880	Study section ZCA1
FY2018	Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations1R33CA229023-01 · under RFA-CA-17-011	Tewari, Muneesh Walter, Nils G	UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI	First-year cost $388,440	Study section ZCA1
FY2018	Multiplex matrix ELISA for T cell protein-interaction networks in cancer1R33CA228979-01 · under RFA-CA-17-011	Schrum, Adam G.	UNIVERSITY OF MISSOURI-COLUMBIA, MO	First-year cost $387,880	Study section ZCA1
FY2018	Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods1R33CA222344-01 · under RFA-CA-17-011	Salipante, Stephen J	UNIVERSITY OF WASHINGTON, WA	First-year cost $386,677	Study section ZCA1
FY2018	High-throughput super-resolution imaging of chromatin structures at different epigenetic states1R33CA225494-01 · under RFA-CA-17-011	Liu, Yang	UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA	First-year cost $351,864	Study section ZCA1
FY2017	Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes1R33CA217652-01 · under RFA-CA-16-002	Makrigiorgos, G. Mike	DANA-FARBER CANCER INST, MA	First-year cost $456,746	Study section ZCA1
FY2017	Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry1R33CA212973-01 · under RFA-CA-16-002	Yates Iii, John R	SCRIPPS RESEARCH INSTITUTE, THE, CA	First-year cost $435,649	Study section ZCA1
FY2017	Droplet microfluidic technology for single cell cancer genomics1R33CA212697-01 · under RFA-CA-16-002	Klein, Allon Moshe	HARVARD MEDICAL SCHOOL, MA	First-year cost $411,954	Study section ZCA1
FY2017	High Resolution High Throughput Proteomics Platform for Cancer Research1R33CA217699-01 · under RFA-CA-16-002	Ibrahim, Yehia	BATTELLE PACIFIC NORTHWEST LABORATORIES, WA	First-year cost $410,858	Study section ZCA1
FY2017	Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer1R33CA214333-01 · under RFA-CA-16-002	Godwin, Andrew K.Samuel, GlensonZeng, Yong	UNIVERSITY OF KANSAS LAWRENCE, KS	First-year cost $400,098	Study section ZCA1
FY2017	Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples1R33CA214176-01 · under RFA-CA-16-002	Lu, Chang	VIRGINIA POLYTECHNIC INST AND ST UNIV, VA	First-year cost $391,723	Study section ZCA1
FY2017	TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES1R33CA217700-01 · under RFA-CA-16-002	Duncavage, Eric J Walter, Matthew J	WASHINGTON UNIVERSITY, MO	First-year cost $379,725	Study section ZCA1
FY2017	Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells1R33CA204704-01A1 · under RFA-CA-16-002	Wang, Yingxiao	UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA	First-year cost $376,821	Study section ZCA1
FY2017	Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy1R33CA202881-01A1 · under RFA-CA-16-002	Levenson, Richard M.	UNIVERSITY OF CALIFORNIA AT DAVIS, CA	First-year cost $373,637	Study section ZCA1
FY2017	LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics1R33CA212968-01 · under RFA-CA-16-002	Singh, Ankur	CORNELL UNIVERSITY, NY	First-year cost $371,216	Study section ZCA1
FY2017	Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity1R33CA217780-01 · under RFA-CA-16-002	Parker, Laurie L.	UNIVERSITY OF MINNESOTA, MN	First-year cost $345,244	Study section ZCA1
FY2017	Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis1R33CA204574-01A1 · under RFA-CA-16-002	Kelley, Shana O	UNIVERSITY OF TORONTO, ON	First-year cost $258,952	Study section ZCA1
FY2016	Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology1R33CA206949-01 · under RFA-CA-15-003	Spicer, Timothy Patrick	SCRIPPS FLORIDA, FL	First-year cost $501,426	Study section ZCA1
FY2016	Clinical implementation of single cell tumor transcriptome analysis1R33CA202820-01 · under RFA-CA-15-003	Regev, Aviv	BROAD INSTITUTE, INC., MA	First-year cost $457,465	Study section ZCA1
FY2016	Analysis of scant cancer cells in fine needle aspirates1R33CA202064-01 · under RFA-CA-15-003	Weissleder, Md, Phd, Ralph	MASSACHUSETTS GENERAL HOSPITAL, MA	First-year cost $433,261	Study section ZCA1
FY2016	A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers1R33CA202900-01 · under RFA-CA-15-003	Breunig, Joshua John	CEDARS-SINAI MEDICAL CENTER, CA	First-year cost $418,128	Study section ZCA1
FY2016	Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma1R33CA196470-01A1 · under RFA-CA-15-003	Lin, Qiao	COLUMBIA UNIV NEW YORK MORNINGSIDE, NY	First-year cost $394,518	Study section ZCA1
FY2016	Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology1R33CA196458-01A1 · under RFA-CA-15-003	Bhargava, RohitCheville, John C	UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL	First-year cost $387,693	Study section ZCA1
FY2016	Charge sensitive optical detection for high-throughput study of small molecules1R33CA202834-01A1 · under RFA-CA-15-003	Tao, Nongjian	ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ	First-year cost $381,382	Study section ZCA1
FY2016	Online Raman Diagnostics of Oncometabolites1R33CA206922-01 · under RFA-CA-15-003	Schultz, Zachary	UNIVERSITY OF NOTRE DAME, IN	First-year cost $363,875	Study section ZCA1
FY2016	GESI: a novel technology for functional imaging in living cells1R33CA196445-01A1 · under RFA-CA-15-003	Lam, Kit S	UNIVERSITY OF CALIFORNIA AT DAVIS, CA	First-year cost $362,749	Study section ZCA1
FY2016	Protein painting identifies therapeutic targets at protein-protein interfaces1R33CA206937-01 · under RFA-CA-15-003	Liotta, Lance Allen	GEORGE MASON UNIVERSITY, VA	First-year cost $348,203	Study section ZCA1
FY2016	High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing1R33CA202867-01 · under RFA-CA-15-003	Nagrath, Sunitha Ramnath, Nithya	UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI	First-year cost $343,664	Study section ZCA1
FY2016	A novel molecular assay for early detection and assessment of cancer risk1R33CA202898-01 · under RFA-CA-15-003	Queimado, Lurdes	UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK	First-year cost $340,594	Study section ZCA1
FY2016	Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors1R33CA206955-01 · under RFA-CA-15-003	Weiss, Gregory A.	UNIVERSITY OF CALIFORNIA-IRVINE, CA	First-year cost $322,131	Study section ZCA1
FY2016	Large-Scale Integration of Single Cell RNA-Seq and High-Content Imaging for Analyzing Drug Response in Cancer1R33CA202827-01 · under RFA-CA-15-003	Sims, Peter Alan	COLUMBIA UNIVERSITY HEALTH SCIENCES, NY	First-year cost $316,149	Study section ZCA1
FY2016	Brillouin confocal microscopy for biomechanical studies of metastatic cascade in 3D microenvironments1R33CA204582-01 · under RFA-CA-15-003	Scarcelli, Giuliano	UNIV OF MARYLAND, COLLEGE PARK, MD	First-year cost $295,733	Study section ZCA1
FY2015	Single cell cytokine analysis of circulating malignant hematopoietic cells1R33CA196411-01 · under RFA-CA-14-004	Fan, Rong Levine, Ross L	YALE UNIVERSITY, CT	First-year cost $421,227	Study section ZCA1
FY2015	High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis1R33CA182384-01A1 · under RFA-CA-14-004	Burke, Peter J.	UNIVERSITY OF CALIFORNIA-IRVINE, CA	First-year cost $412,541	Study section ZCA1
FY2015	Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis1R33CA191245-01A1 · under RFA-CA-14-004	Wu, Yun	STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY	First-year cost $411,504	Study section ZCA1
FY2015	Development of a virion display (VirD) array to profile human GPCR interactions1R33CA186790-01A1 · under RFA-CA-14-004	Desai, Prashant J Zhu, Heng	JOHNS HOPKINS UNIVERSITY, MD	First-year cost $403,372	Study section ZCA1
FY2015	A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes1R33CA191198-01 · under RFA-CA-14-004	Caron, Marc G.	DUKE UNIVERSITY, NC	First-year cost $389,963	Study section ZCA1
FY2015	Using Adductomics to Characterize Exposures to Carcinogens1R33CA191159-01A1 · under RFA-CA-14-004	Rappaport, Stephen Morris	UNIVERSITY OF CALIFORNIA BERKELEY, CA	First-year cost $380,395	Study section ZCA1
FY2015	Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations1R33CA192980-01 · under RFA-CA-14-004	Salipante, Stephen J	UNIVERSITY OF WASHINGTON, WA	First-year cost $375,858	Study section ZCA1
FY2015	Scalable Cancer Genomics via Nanocoding and Sequencing1R33CA182360-01A1 · under RFA-CA-14-004	Ma, Jian Schwartz, David C.	UNIVERSITY OF WISCONSIN-MADISON, WI	First-year cost $372,503	Study section ZCA1
FY2015	Fast interference-based super-resolution microscope for cancer mechanobiology1R33CA193043-01 · under RFA-CA-14-004	Zipfel, Warren R	CORNELL UNIVERSITY, NY	First-year cost $364,273	Study section ZCA1
FY2015	Single cell growth assay for residual cells in acute lymphoblastic leukemia1R33CA191143-01 · under RFA-CA-14-004	Manalis, Scott R	MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA	First-year cost $363,946	Study section ZCA1
FY2015	RASL-Seq Expression Profiling of FFPE Tissues1R33CA183688-01A1 · under RFA-CA-14-004	Yeakley, Joanne Mulligan	BIOSPYDER TECHNOLOGIES, INC., CA	First-year cost $363,706	Study section ZCA1
FY2015	Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research1R33CA191110-01 · under RFA-CA-14-004	Borges, Chad R	ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ	First-year cost $317,654	Study section ZCA1
FY2014	Integrating mass cytometric and transcriptomic profiles of solid tumors1R33CA183692-01 · under RFA-CA-13-002	Weiss, William A	UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA	First-year cost $408,712	Study section ZCA1
FY2014	Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci1R33CA183659-01 · under RFA-CA-13-002	Robinson, William H	STANFORD UNIVERSITY, CA	First-year cost $399,643	Study section ZCA1
FY2014	Validation and Advanced Development of Duplex Sequencing1R33CA181771-01A1 · under RFA-CA-13-002	Loeb, Lawrence A	UNIVERSITY OF WASHINGTON, WA	First-year cost $384,923	Study section ZCA1
FY2014	Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics1R33CA177333-01A1 · under RFA-CA-13-002	Federspiel, Mark J	MAYO CLINIC ROCHESTER, MN	First-year cost $375,008	Study section ZCA1
FY2014	Non-Circulating Microparticles for Improved Localization and Resection Cancer1R33CA177449-01A1 · under RFA-CA-13-002	Blair, Sarah L	UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA	First-year cost $361,766	Study section ZCA1
FY2014	Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp1R33CA183671-01 · under RFA-CA-13-002	Parker, Laurie L.	UNIVERSITY OF MINNESOTA, MN	First-year cost $341,454	Study section ZCA1

Newest fiscal year first, then first-year cost.

Patents from its funded projects

32 patents name 19 of the 77 funded projects. The newest 5, by patent number.

US 12,721,607 (opens the patent at USPTO, a PDF, in a new tab)COLLAPSIBLE FLUID COLLECTION SYSTEM FOR POINT-OF-CARE DIAGNOSTICSGranted September 1, 2026 to George Mason UniversityR33CA206937 · GEORGE MASON UNIVERSITY, VA
US 12,702,696 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND COMPOSITION FOR MODULATING IMMUNE RESPONSE AND IMMUNE HOMEOSTASISGranted August 11, 2026 to Massachusetts Institute of Technology and President and Fellows of Harvard CollegeR33CA202820 · BROAD INSTITUTE, INC., MA
US 12,697,398 (opens the patent at USPTO, a PDF, in a new tab)COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED IMMUNE-GENE THERAPYGranted August 4, 2026 to Yale UniversityR33CA225498 · YALE UNIVERSITY, CT
US 12,693,295 (opens the patent at USPTO, a PDF, in a new tab)METHODS FOR INKJET PRINTING OBJECTS FOR MICROFLUIDIC DEVICESGranted July 28, 2026 to University of KansasR33CA214333 · UNIVERSITY OF KANSAS LAWRENCE, KS
US 12,655,471 (opens the patent at USPTO, a PDF, in a new tab)RNA Printing and Sequencing Devices, Methods, and SystemsGranted June 16, 2026 to The Trustees of Columbia University in the City of New YorkR33CA202827 · COLUMBIA UNIVERSITY HEALTH SCIENCES, NY

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)